>
pdufa.bio

Loncastuximab Tesirine

Updated ยทnext FDA decision on the calendar

Loncastuximab Tesirine is a ADC Therapeutics SA program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

ADCT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: ADC Therapeutics SA (ADCT). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026ADCT

Questions

When is Loncastuximab Tesirine's next FDA decision or readout?

The next tracked catalyst for Loncastuximab Tesirine is a Readout in Dec 2026.

What happened at Loncastuximab Tesirine's most recent FDA decision?

No FDA decision for Loncastuximab Tesirine is in our archive yet.

Who makes Loncastuximab Tesirine?

ADC Therapeutics SA (ADCT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.